The KS WEL Institute empowers and spotlights female-owned startups monthly through their application-based Featured Female Founders program. The Featured Female Founders program provides resources and exposure to the Austin startup community for these founders. Come stop by the KS WEL Institute or apply online if you're interested in becoming a Featured Female Founder!

Hosted by the Texas Innovation Center, KS WEL Institute's Female Founder Pitch Competition showcases emerging businesses and technologies that are paving the way to have a significant impact on the world. Open to all UT Austin undergraduate and graduate students, faculty, alumnae, and startup ecosystem women-founders, this startup competition aims to highlight innovation happening in the heart of Texas.

Genesis is a student-alumni partnership with over $1.8 million to distribute to student-founded companies through non-dilutive grants, along with the time and talent of our diverse and entrepreneurial leadership team. Genesis has helped founders develop their businesses, build their products, generate their first revenue, recruit cofounders and early employees, brainstorm ideas, and raise future funding from top investors. All students can apply for funding and mentorship.

The Kendra Scott Women’s Entrepreneurial Leadership Institute (KS WELI) supports creatives, founders, leaders, and allies by redefining leadership and entrepreneurship. KS WELI equips and empowers students of all backgrounds through engaging programming and events, spotlighting women-led businesses through the FoundHER Program, and sponsoring interdisciplinary courses within the McCombs Entrepreneurship Minor. Since its founding, KS WELI has become a force on UT’s campus to grow and support the number of women-owned and women-led businesses.

The Office of Industry Engagement (OIE) negotiates all contracts related to private industry research funding. OIE endeavors to streamline negotiations to better accommodate industry financial cycles and assist UT faculty in their collaborative efforts with industry partners. OIE focuses on flexible engagements and expedited contractual negotiations, through collaboration with internal and external stakeholders and with support from the Office of Technology Commercialization.

The Texas Global Health Security Innovation Consortium (TEXGHS) connects academic, public- and private-sector partners to support companies working towards pandemic preparedness and response in Texas. TEXGHS is developing a health security innovation ecosystem that supports innovators and innovations fighting COVID-19 and future pandemics. UT Austin entrepreneurs should contact TEXGHS when they are seeking to commercialize infectious disease-related innovations at any stage of development.

Texas Health Catalyst supports the translation of promising ideas and discoveries into solutions that improve health outcomes and lower health care costs. The program provides support through timely and customized guidance on the research and development pathway from industry and clinical experts (Phase 1 awards), as well as seed funding for awardees (Phase 2 awards of $5K-$50K per project).

Founded in 2010, the Texas Venture Labs Accelerator is a zero-cost, zero equity program that connects Texas startups with multi-disciplinary graduate student teams. These students provide up to 200 hours of high impact business consulting each spring and fall semester. We accept applications from both early stage and growth stage startups who can clearly define meaningful projects to help accelerate growth and are committed to engaging with the student team.

Texas Venture Mentoring Service (TEXVMS) has assembled over 100 expert mentors to support startups in the many entrepreneurship programs at UT Austin. TEXVMS's intensive team mentoring methodology surrounds startups with diverse expertise tailored to each company's unique needs. Mentors provide practical, actionable advice with a focus on developing the entrepreneur. Startups with any UT Austin connection may apply: university IP, faculty/student founder, or participation in another UT program.

Drug development services including preclinical evaluation (animal and analytical), development, and translation of drug products and technologies that improve healthcare outcomes. Access to equipment and services, such as small animal studies (mice, rats, hamsters), cell culture, material characterization (NGI, Spraytec, Zetasizer), formulation development, dissolution and stability studies, as well as quantitative small molecule HPLC and mass spec analyses.